The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Marinus Pharmaceuticals Retains The Chase Group for Chief Medical Officer

March 16, 2017

Marinus Pharmaceuticals selected The Chase Group when they began their search for a new Chief Medical Officer. The Chase Group has had an on-going relationship with Marinus and because of the success with previous recruitments, the company put their trust in the team at TCG who has quickly secured a strong candidate slate for Christopher Cashman, Chairman and CEO, to make his final selection.

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

Chase Group

Share This News Post

© Copyright 1993-2019 The Chase Group; All Rights Reserved.